News

Fund Flows

Reuters | Equities.com |

U.S. healthcare exchange traded funds (ETFs) have led inflows in November, bolstered by the progress in development of coronavirus vaccines.

Data from Morningstar showed U.S. healthcare ETFs have lured $1.7 billion in the first two weeks of this month after witnessing outflows in the past three months.

The news that Pfizer and German partner BioNTech SE's experimental COVID-19 vaccine was more than 90% effective based on initial trial results lifted healthcare stocks last week.

Increasing COVID-19 cases and proposals for new lockdowns in the United States, however, have tempered some market optimism and prompted investors to look for safer stocks.